Page 67 - congress

ORAL PRESENTATION / TAM METİN SÖZLÜ SUNUM

Sun Z, Zhao N, Zhao X, Wang Z, Liu Z, Cui Y. (2024). Application of physiologically based
pharmacokinetic modeling of novel drugs approved by the US food and drug administration.
European Journal of Pharmaceutical Sciences, 106838.
T’jollyn H, Vermeulen A, Van Bocxlaer J. (2019). PBPK and its virtual populations: the impact of
physiology on pediatric pharmacokinetic predictions of tramadol. The AAPS Journal, 21, 1-12.
Tylutki Z, Polak S, Wiśniowska B. (2016). Top-down, bottom-up and middle-out strategies for drug
cardiac safety assessment via modeling and simulations. Current Pharmacology Reports, 2,
171-177.
US Food and Drug Administration (2018). Physiologically Based Pharmacokinetic Analyses: Format
and Content Guidance for Industry. Erişim Tarihi: 05.06.2025, Saat: 17.07, Erişim Adresi:
https://www.fda.gov/regulatory-information/search-fda-guidance-
documents/physiologically-based-pharmacokinetic-analyses-format-and-content-guidance-
industry.
Wang W, Wang N, Wu Y, Ye Z, Zhao L, Chen X, Ouyang D. (2025). An Integrated AI‐PBPK Platform
for Predicting Drug In Vivo Fate and Tissue Distribution in Human and Inter‐Species
Extrapolation. Clinical Pharmacology & Therapeutics.
Wu D, Li M. (2023). Current state and challenges of physiologically based biopharmaceutics
modeling (PBBM) in oral drug product development. Pharmaceutical Research, 40(2), 321-
336.
Zhang W, Zhang Q, Cao Z, Zheng L, Hu W. (2023). Physiologically based pharmacokinetic modeling
in neonates: Current status and future perspectives. Pharmaceutics, 15(12), 2765.
Zhou K, Mi K, Ma W, Xu X, Huo M, Algharib SA, Pan Y, Xie S, Huang L. (2021). Application of
physiologically based pharmacokinetic models to promote the development of veterinary
drugs with high efficacy and safety. Journal of Veterinary Pharmacology and Therapeutics,
44(5), 663-678.
Zhou X, Dun J, Chen X, Xiang B, Dang Y, Cao D. (2023). Predicting the correct dose in children: Role
of computational Pediatric Physiological‐based pharmacokinetics modeling tools. CPT:
pharmacometrics & systems pharmacology, 12(1), 13-26.

64